Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
YSG · NYSE · United States · Perfumes, Cosmetics & Other Toilet Preparations
In shortYatsen Holding Ltd is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -4.3% | 2/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -1.9% | 12/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -2.7% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 3.63× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -0.73 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -3.2% | 7/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 23.6% | 24/100 |
| Operating margin volatility | 9.8% | 20/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 5.1% | 45/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CNY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 5,840 | 3,706 | 3,415 | 3,393 | 4,298 |
| Cost of revenue | 1,941 | 1,187 | 901 | 776 | 937 |
| Gross profit | 3,899 | 2,519 | 2,513 | 2,617 | 3,361 |
| Research & development | 142 | 127 | 112 | 109 | 137 |
| Operating income | (1,624) | (929) | (913) | (825) | (186) |
| Pre-tax income | (1,548) | (819) | (753) | (713) | (93) |
| Income tax | (0.9) | 2.7 | (3.2) | (3.1) | (0.1) |
| Net income | (1,541) | (815) | (748) | (708) | (81) |
| Diluted EPS | −¥0.61 | −¥0.34 | −¥0.34 | −¥0.35 | −¥0.04 |
| Diluted shares (millions) | 2,527 | 2,373 | 2,196 | 2,025 | 1,863 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
−0.73 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Apr 29, 2026